Extravasation of immune and tumor cells from an endothelial perspective.

Fiche publication

Date publication

novembre 2024

Journal

Journal of cell science

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GOETZ Jacky , Dr OSMANI Naël

Tous les auteurs :
Dupas A, Goetz JG, Osmani N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39530179

Résumé

Crossing the vascular endothelium is a necessary stage for circulating cells aiming to reach distant organs. Leukocyte passage through the endothelium, known as transmigration, is a multistep process during which immune cells adhere to the vascular wall, migrate and crawl along the endothelium until they reach their exit site. Similarly, circulating tumor cells (CTCs), which originate from the primary tumor or reseed from early metastatic sites, disseminate using the blood circulation and also must cross the endothelial barrier to set new colonies in distant organs. CTCs are thought to mimic arrest and extravasation utilized by leukocytes; however, their extravasation also requires processes that, from an endothelial perspective, are specific to cancer cells. Although leukocyte extravasation relies on maintaining endothelial impermeability, it appears that cancer cells can indoctrinate endothelial cells into promoting their extravasation independently of their normal functions. In this Review, we summarize the common and divergent mechanisms of endothelial responses during extravasation of leukocytes (in inflammation) and CTCs (in metastasis), and highlight how these might be leveraged in the development of anti-metastatic treatments.